Antibiotic Resistance: A Primer and Call to Action

Health Communication

Volumn 30, Issue 3, 2015, Pages 309-314

  Smith, Rachel A ^a   M’ikanatha, Nkuchia M ^b   Read, Andrew F ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENNSYLVANIA DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTIONS; COST OF ILLNESS; HUMAN; MEDICAL INFORMATION; PUBLIC HEALTH;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COST OF ILLNESS; DRUG RESISTANCE, MICROBIAL; HEALTH COMMUNICATION; HUMANS; PUBLIC HEALTH;

EID: 84919844859     PISSN: 10410236     EISSN: 15327027     Source Type: Journal    
DOI: 10.1080/10410236.2014.943634     Document Type: Article

References (25)

1. Ackerman, S. L., Gonzales, R., Stahl, M. S., & Metlay, J. P. (2013). One size does not fit all: Evaluating an intervention to reduce antibiotic prescribing for acute bronchitis. BMC Health Services Research, 13, 1–9. doi:10.1186/1472-6963-13-462
2. Ankomah, P., & Levin, B. R. (2014). Exploring the collaboration between antibiotics and the immune response in the treatment of acute self-limiting infections. Proceedings of the National Academy of Sciences USA. Advance online publication. doi:10.1073/pnas.1400352111
3. Barnett, M. L., & Linder, J. A. (2014). Antibiotic prescribing for adults with acute bronchitis in the United States, 1996–2010. Journal of the American Medical Association. 311, 2020–2022.
4. Centers for Disease Control and Prevention. (2013). Antibiotic resistance threats in the United States, 2013. Retrieved from http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf
5. Coates, A. R., Halls, G., & Hu, Y. (2011). Novel classes of antibiotics or more of the same? British Journal of Pharmacology, 163, 184–194. doi:10.1111/j.1476-5381.2011.01250.x
6. D’Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006). Sampling the antibiotic resistome. Science, 311, 374–377.
7. Davies, J., & Davies, D. (2010). Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology Reviews, 74, 417–433. doi:10.1128/MMBR.00016-10
8. Fauci, A. S., & Marston, H. D. (2014). The perpetual challenge of antimicrobial resistance. Journal of the American Medical Association. Advance online publication. doi:10.1001/jama.2014.2465
9. Gahbauer, A. M., Gonzales, M. L., & Guglielmo, B. J. (2014). Patterns of antibacterial use and impact of age, race/ethnicity, and geographic region on antibacterial use in an outpatient medicaid cohort. Pharmacotherapy. Advance online publication. doi:10.1002/phar.1425
10. Gonzales, R., Corbett, K. K., Wong, S., Glazner, J. E., Deas, A., Leeman-Castillo, B., … Kafadar, K. (2008). “Get smart Colorado”: Impact of a mass media campaign to improve community antibiotic use. Medical Care, 46, 597–605. doi:10.1097/MLR.0b013e3181653d2e
11. Hicks, L. A., & Taylor, T. H. (2013). U.S. outpatient antibiotic prescribing, 2010. New England Journal of Medicine, 368, 1461–1462. doi:10.1056/NEJMc1212055
12. Hornik, R., & Woolf, K. D. (1999). Using cross-sectional surveys to plan message strategies. Social Marketing Quarterly, 5, 34–41. doi:10.1080/15245004.1999.9961044
13. Huijben, S., Bell, A. S., Sim, D. G., Tomasello, D., Mideo, N., Day, T., & Read, A. (2013) Aggressive chemotherapy and the selection of drug resistant pathogens. PLoS Pathogens 9(9), e1003578. doi:10.1371/journal.ppat.1003578
14. Lederberg, J. (2000). Infectious history. Science, 288, 287–293. doi:10.1126/science.288.5464.287
15. Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., … Fridkin, M. D. (2014). Multistate point-prevalence survey of health care-associated infections. New England Journal of Medicine, 370, 1198–1208. doi:10.1056/NEJMoa1306801
16. M’ikanatha, N., Dewar, R. F., Rankin, S. C., & Lautenbach, E. (2007, October). Prevalence of antibiotic prescriptions and attitudes toward antibiotic-free food. Poster presented at the annual meeting of the Infectious Diseases Society of America, San Diego, CA.
17. Miller, C. P. (1947). Development of bacterial resistance to antibiotics. Journal of the American Medical Association, 135, 749–751. PMID:18897582
18. Parrott, R. L., & Kreuter, M. W. (2011). Multidisciplinary, interdisciplinary, and transdisciplinary approaches to health communication: Where do we draw the lines? In T. L. Thompson, R. Parrott, & J. F. Nussbaum (Eds.), The Routledge handbook of health communication (2nd ed., pp. 3–17). New York, NY: Routledge.
19. Peleg, A. Y., & Hooper, D. C. (2010). Hospital-acquired infections due to gram-negative bacteria. New England Journal of Medicine, 362, 1804–1813. doi:10.1056/NEJMra0904124
20. Pittet, D., & Boyce, J. M. (2001). Hand hygiene and patient care: Pursuing the Semmelweis legacy. Lancet Infectious Diseases, 1, 9–20. doi:10.1016/S1473-3099(09)70295-6
21. Read, A. F., Day, T., & Huijben, S. (2011) The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy. Proceedings of the National Academy of Sciences USA, 108, 10871–10877.
22. U.S. Census Bureau. (2012). American community survey, 2012. Retrieved from http://factfinder2.census.gov
23. Venkatesan, A. K., & Halden, R. U. (2014). Wastewater treatment plants as chemical observatories to forecast ecological and human health risks of manmade chemicals. Scientific Reports, 4, 1–7. doi:10.1038/srep03731
24. World Health Organization. (2014). Antimicrobial resistance: Global report on surveillance. Geneva, Switzerland: WHO.
25. Zur Wiesch, P. A., Kouyos, R., Engelstadter, J., Regoes, R. R., & Bonhoeffer, S. (2011). Population biological principles of drug-resistance evolution in infectious diseases. Lancet Infectious Diseases, 11, 236–247. doi:10.1016/S1473-3099(10)70264-4